Jennifer D Stone

4PUBLICATIONS
29CO-AUTHORS
Gene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 28, 2025
ABBV-303 Is an NK-cell Engager Specific for c-Met-Expressing Tumors.

Jennifer D Stone, Kamonwan Fish, Devika Ashok

|Jun 09, 2023
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies.

Adam S Chervin, Jennifer D Stone, Iwona Konieczna

|Sep 25, 2019
T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity.

Preeti Sharma, Daniel T Harris, Jennifer D Stone

|Dec 31, 2017
Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains.

Daniel T Harris, Marlies V Hager, Sheena N Smith

Pageof 1

Frequent Collaborators

2 joint publications

Edward B Reilly

2 joint publications

Adam S Chervin

2 joint publications

Joann P Palma

2 joint publications

Cormac Cosgrove